We are live on ! Find out more
INSP icon

Inspire Medical Systems

171 hedge funds and large institutions have $1.65B invested in Inspire Medical Systems in 2019 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 57 increasing their positions, 48 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

455% more call options, than puts

Call options by funds: $30M | Put options by funds: $5.4M

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

24% more capital invested

Capital invested by funds: $1.33B → $1.65B (+$319M)

19% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 48

10% more funds holding

Funds holding: 155171 (+16)

1.2% more ownership

Funds ownership: 91.24%92.44% (+1.2%)

20% less funds holding in top 10

Funds holding in top 10: 54 (-1)

Holders
171
Holders Change
+16
Holders Change %
+10.32%
% of All Funds
3.37%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.08%
New
37
Increased
57
Reduced
48
Closed
20
Calls
$30M
Puts
$5.4M
Net Calls
+$24.6M
Net Calls Change
-$26.7M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$136M -$6.09M -94,720 -5%
Morgan Stanley
2
Morgan Stanley
New York
$127M -$20.7M -321,413 -16%
O
3
OrbiMed
New York
$100M -$7.97M -124,000 -8%
William Blair Investment Management
4
William Blair Investment Management
Illinois
$88.4M +$4.67M +72,666 +6%
Invesco
5
Invesco
Georgia
$73.8M -$2.08M -32,420 -3%
Lord, Abbett & Co
6
Lord, Abbett & Co
New Jersey
$72.9M -$6.99M -108,819 -10%
Franklin Resources
7
Franklin Resources
California
$69.3M +$3.6K +56 +0%
Vanguard Group
8
Vanguard Group
Pennsylvania
$63.4M +$1.83M +28,534 +3%
CCI
9
Columbus Circle Investors
$52.2M +$5.88M +91,463 +15%
CIP
10
Champlain Investment Partners
Vermont
$49.2M +$23.6M +366,575 +124%
WA
11
Wasatch Advisors
Utah
$48.5M +$2.24M +34,792 +6%
Victory Capital Management
12
Victory Capital Management
Texas
$48.3M +$11M +171,468 +36%
TCM
13
TimesSquare Capital Management
New York
$39.2M -$866K -13,480 -2%
DCM
14
Driehaus Capital Management
Illinois
$38.1M -$5.76M -89,614 -15%
GGHC
15
Gilder Gagnon Howe & Co
New York
$37.8M +$14.4M +223,317 +78%
KXA
16
KPCB XII Associates
California
$29.4M
PVI
17
Pura Vida Investments
New York
$28.5M +$1.67M +25,940 +7%
D.E. Shaw & Co
18
D.E. Shaw & Co
New York
$26.8M +$67.8K +1,055 +0.3%
BAMCO Inc
19
BAMCO Inc
New York
$26.2M
Federated Hermes
20
Federated Hermes
Pennsylvania
$24.7M -$707 -11 -0%
State Street
21
State Street
Massachusetts
$20.8M +$578K +8,985 +3%
Loomis, Sayles & Company
22
Loomis, Sayles & Company
Massachusetts
$20.3M +$17.6M +273,791 New
Thrivent Financial for Lutherans
23
Thrivent Financial for Lutherans
Minnesota
$20M +$2.61M +40,670 +18%
ACM
24
Atika Capital Management
New York
$19.7M +$2.64M +41,000 +18%
BG
25
Bellevue Group
Switzerland
$19.5M +$1.27M +19,760 +8%

INSP Hedge Fund Activity: Q4 2019 in Review

171 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Inspire Medical Systems (INSP) for Q4 2019, worth a combined $1.65B — up 24% from $1.33B a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new INSP positions and 20 closed out — a net gain of 17 holders — while 57 added to existing stakes and 48 trimmed.

The largest buyer was Champlain Investment Partners, adding an estimated $23.6M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $21.4M sold.

  • 171 institutional investors held Inspire Medical Systems (INSP) as of Q4 2019, up from 155 in Q3 2019.
  • Funds reported $1.65B of Inspire Medical Systems stock for Q4 2019, up 24% quarter-over-quarter.
  • 37 funds opened new Inspire Medical Systems positions in Q4 2019 and 20 closed out, a net change of +17 holders.
  • The largest Inspire Medical Systems buyer in Q4 2019 was Champlain Investment Partners, an estimated $23.6M added.
  • The largest Inspire Medical Systems seller in Q4 2019 was PFM Health Sciences, an estimated $21.4M sold.

Based on aggregated 13F filings for Q4 2019.